ISSUE 88 I NOVEMBER 2019

The Dengue

Dilemma

As nations race to control outbreaks of Dengue Fever, the one and only vaccine is surrounded in controversy – but, why?

In association with

In association with

Drug patents: fit for purpose?

Non-hormonal menopause treatments

Revolutionise post transplant care

02/23/2024 23:27:25

10/29/2019 00:00:00

Go to article: Home | The dengue dilemma Go to article: In this issue Go to article: Owen Mumford Go to article: Contents Go to article: Hapa Company Insight Go to article: Daiichi Jitsugyo Go to article: News Go to article: Embocaps Go to article: HOF Sonderanlagenbau Company Insight Go to article: HOF Sonderanlagenbau Go to article: The pharma industry briefing Go to article: Dow Europe Company Insight Go to article: Gerteis Company Insight Go to article: Gerteis Go to article: The problem of manipulated data Go to article: Capsugel Company Insight Go to article: Capsugel Go to article: Timeline: the dengue vaccine dilemma Go to article: TSS Company Insight Go to article: TSS Go to article: From evergreening to thicketing: exploring manipulation of the pharma patent sys Go to article: Emirates SkyCargo Go to article: AtoZ-CRO Company Insight Go to article: AtoZ-CRO Go to article: A safer ride: the latest innovation in targeted cancer treatment Go to article: Swiss WorldCargo Go to article: Accurate Biometrics Go to article: Accurate Biometrics Company Insight Go to article: Nelson Labs Go to article: Treading the line: the challenge of transplant rejection drugs Go to article: Corbion Purac Go to article: Erdmann Design Company Insight Go to article: Erdmann Design Switzerland Go to article: Treating menopause: at last a non-hormonal alternative? Go to article: Yourway Go to article: ImmuMap Company Insight Go to article: ImmuMap Go to article: Drug repurposing: the industry’s all-rounder medicines Go to article: Fargo Go to article: Pharma Support Services Company Insight Go to article: Pharma Support Services Go to article: One step closer to a Chlamydia vaccine Go to article: Aralab Go to article: Synex Synthetics Go to article: Deals in brief powered by GlobalData Go to article: Charles Ischi Go to article: The key list powered by GlobalData Go to article: Pharmaceutical Solutions Industry Go to article: Clinichain Company Insight Go to article: Clinichain Go to article: Sanofi Go to article: Events Go to article: Nymi Go to article: Modality Solutions Go to article: Pfanstiehl Go to article: Next issue Go to article: Mimotopes Go to article: ICCI - International Cannabis and Cannabinoids Institute Go to article: ICCI